Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » JP Morgan Assigns Overweight Ratings to Thermo Fisher, Qiagen

JP Morgan Assigns Overweight Ratings to Thermo Fisher, Qiagen

Aug 20, 2020
|
staff reporter

NEW YORK – Investment bank JP Morgan has assigned an Overweight rating to the stocks of both Thermo Fisher Scientific and Qiagen a week after Thermo Fisher's planned acquisition of Qiagen fell through due to resistance from a substantial portion of Qiagen shareholders.

JP Morgan moved to an Overweight rating on both companies from a Not Rated designation assigned during a restriction period as the potential acquisition played out.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

EUA Now Sought

Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Former Minister's Paper Retracted

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

Mink Cull and a Prime Minister

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

Science Presents Prize Winner for Single-Cell Genomic Methods, Study of Erlotinib Insensitivity in Triple-Negative Breast Cancer

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

What's Popular?

In Molecular Diagnostics

  1. Progenity to Cut Workforce as Third-Party Payor Seeks $27.4M for Alleged Overpayment

  2. Burning Rock Adds New Data Supporting Cancer Screening Liquid Biopsy, Automated NGS Products

    Premium

  3. Burning Rock Q3 Revenues Up 19 Percent

  4. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

  5. FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.